As the race for COVID–19 vaccines enters its next stage, we are faced with broad ethical challenges, along with specific questions of principle and practice. How will the private companies developing these vaccines balance their commercial interests with the public good? Once the vaccines are ready for distribution, how should countries and the global community plan for distribution and allocation? And with so much skepticism about both commercial and political interests, what can and should be done to bolster trust across populations and targeted to specific communities?

On Thursday, December 3, from 12:00pm ET to 1:30pm ET, Dr. Jeffrey Kahn, director of the Johns Hopkins Berman Institute of Bioethics, will moderate a discussion on the ethics of the COVID-19 vaccines. Join us for this important discussion on a timely subject.